STIGALL L. JEREMY 4
4 · ClearPoint Neuro, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
STIGALL L. JEREMY
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-03+8,856→ 81,212 total - Tax Payment
Common Stock
[F2]2026-03-03$8.84/sh−4,506$39,833→ 76,706 total - Exercise/Conversion
Restricted Stock Units
[F1]2026-03-03−8,856→ 35,424 total→ Common Stock (8,856 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Jeremy L. Stigall|2026-03-05